Liesenfeld, Oliver
Inflammatix, Inc.,
United States
2025 Rank: 130035
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Microbiology
SubField 2:
Mycology & Parasitology
Rank in SubField 1: 2516 out of 217955 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 130035 | 134305 |
| Total Cites | 640 | 697 |
| H-index | 8 | 9 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 10 | 10 |
| Number of Single+First Authored Papers | 18 | 18 |
| Total Cites to Single+First Authored Papers | 45 | 46 |
| Number of Single+First+Last Authored Papers | 69 | 69 |
| Total Cites to Single+First+Last Authored Papers | 319 | 329 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 503 | 526 |
| Ratio of Total Citations to Distinct Citing Papers | 1.27 | 1.33 |
| Self-Citation Percentage |
8.18%
|
|
Liesenfeld, Oliver
Roche Molecular Diagnostics,
United States
2022 Rank: 90572
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Microbiology
SubField 2:
Mycology & Parasitology
Rank in SubField 1: 2128 out of 175943 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 90572 | 92520 |
| Total Cites | 687 | 758 |
| H-index | 9 | 10 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 9 | 9 |
| Number of Single+First Authored Papers | 18 | 18 |
| Total Cites to Single+First Authored Papers | 45 | 45 |
| Number of Single+First+Last Authored Papers | 67 | 67 |
| Total Cites to Single+First+Last Authored Papers | 400 | 416 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 530 | 561 |
| Ratio of Total Citations to Distinct Citing Papers | 1.30 | 1.35 |
| Self-Citation Percentage |
9.37%
|
|
Liesenfeld, Oliver
Inflammatix,
United States
2021 Rank: 96281
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Microbiology
SubField 2:
Mycology & Parasitology
Rank in SubField 1: 2160 out of 165244 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 96281 | 100884 |
| Total Cites | 1007 | 1106 |
| H-index | 11 | 13 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 9 | 9 |
| Number of Single+First Authored Papers | 18 | 18 |
| Total Cites to Single+First Authored Papers | 59 | 59 |
| Number of Single+First+Last Authored Papers | 67 | 67 |
| Total Cites to Single+First+Last Authored Papers | 588 | 618 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 779 | 826 |
| Ratio of Total Citations to Distinct Citing Papers | 1.29 | 1.34 |
| Self-Citation Percentage |
8.95%
|
|
Liesenfeld, Oliver
Inflammatix, Inc,
United States
2020 Rank: 89928
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Microbiology
SubField 2:
Mycology & Parasitology
Rank in SubField 1: 1863 out of 134369 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 89928 | 96954 |
| Total Cites | 714 | 789 |
| H-index | 10 | 11 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 9 | 9 |
| Number of Single+First Authored Papers | 18 | 18 |
| Total Cites to Single+First Authored Papers | 48 | 52 |
| Number of Single+First+Last Authored Papers | 67 | 67 |
| Total Cites to Single+First+Last Authored Papers | 415 | 438 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 572 | 605 |
| Ratio of Total Citations to Distinct Citing Papers | 1.25 | 1.30 |
| Self-Citation Percentage |
9.51%
|
|
Related Profiles
.jpg)
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.